BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8873890)

  • 1. Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans.
    Jacobson ES; Compton GM
    J Med Vet Mycol; 1996; 34(4):289-91. PubMed ID: 8873890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature regulation of the cryptococcal phenoloxidase.
    Jacobson ES; Emery HS
    J Med Vet Mycol; 1991; 29(2):121-4. PubMed ID: 1908897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cryptococcal capsular polysaccharide by iron.
    Vartivarian SE; Anaissie EJ; Cowart RE; Sprigg HA; Tingler MJ; Jacobson ES
    J Infect Dis; 1993 Jan; 167(1):186-90. PubMed ID: 8418165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans.
    Polacheck I; Hearing VJ; Kwon-Chung KJ
    J Bacteriol; 1982 Jun; 150(3):1212-20. PubMed ID: 6804439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different K+ concentrations on Cryptococcus neoformans phenoloxidase activity.
    Vidotto V; Defina N; Pugliese A; Aoki S; Nakamura K; Takeo K
    Mycopathologia; 2002; 156(3):171-6. PubMed ID: 12749580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.
    Rhodes JC; Polacheck I; Kwon-Chung KJ
    Infect Immun; 1982 Jun; 36(3):1175-84. PubMed ID: 6807845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.
    Zaragoza O; Chrisman CJ; Castelli MV; Frases S; Cuenca-Estrella M; Rodríguez-Tudela JL; Casadevall A
    Cell Microbiol; 2008 Oct; 10(10):2043-57. PubMed ID: 18554313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and virulence of Cryptococcus neoformans.
    Polacheck I; Platt Y; Aronovitch J
    Infect Immun; 1990 Sep; 58(9):2919-22. PubMed ID: 2117574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
    Pini G; Faggi E; Campisi E
    Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
    Nosanchuk JD; Casadevall A
    Infect Immun; 1997 May; 65(5):1836-41. PubMed ID: 9125569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanin-deficient mutants of Cryptococcus neoformans.
    Torres-Guererro H; Edman JC
    J Med Vet Mycol; 1994; 32(4):303-13. PubMed ID: 7983575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol peroxidase is critical for virulence and resistance to nitric oxide and peroxide in the fungal pathogen, Cryptococcus neoformans.
    Missall TA; Pusateri ME; Lodge JK
    Mol Microbiol; 2004 Mar; 51(5):1447-58. PubMed ID: 14982637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The phenoloxidase test and its application to identify Cryptococcus neoformans with various biological characteristics].
    Li A; Wu S
    Wei Sheng Wu Xue Bao; 1995 Apr; 35(2):97-102. PubMed ID: 7483579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.
    Blackstock R; Buchanan KL; Cherniak R; Mitchell TG; Wong B; Bartiss A; Jackson L; Murphy JW
    Mycopathologia; 1999; 147(1):1-11. PubMed ID: 10872510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings.
    Vidotto V; Leone R; Sinicco A; Ito-kuwa S; Criseo G
    Mycopathologia; 1998; 142(2):71-6. PubMed ID: 9926419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages.
    Chrisman CJ; Albuquerque P; Guimaraes AJ; Nieves E; Casadevall A
    PLoS Pathog; 2011 May; 7(5):e1002047. PubMed ID: 21637814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What makes Cryptococcus neoformans a pathogen?
    Buchanan KL; Murphy JW
    Emerg Infect Dis; 1998; 4(1):71-83. PubMed ID: 9452400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice.
    Kwon-Chung KJ; Polacheck I; Popkin TJ
    J Bacteriol; 1982 Jun; 150(3):1414-21. PubMed ID: 6804444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential of propolis on major virulence factors of Cryptococcus neoformans.
    Thammasit P; Iadnut A; Mamoon K; Khacha-Ananda S; Chupradit K; Tayapiwatana C; Kasinrerk W; Tragoolpua Y; Tragoolpua K
    Microb Pathog; 2018 Oct; 123():296-303. PubMed ID: 30041002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
    Granger DL; Perfect JR; Durack DT
    J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.